Track FBRX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Forte Biosciences Inc
3060 Pegasus Park Drive, Dallas, TX, United States, 75247
IPO
2017
Employees
22
Industry
Biotechnology
Sector
Healthcare
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q4 20240+1
1
Q4 20230+6
6
2-quarter cumulative
0 sells7 buys
Analyst Ratings
No coverage data
No analyst ratings data available